
Address
OrbiMed Advisors LLC
767 Third Avenue
30th Floor
New York, NY 10017
United States
Phone
Website
Industry
Business classification
VCID: 29979
Profile
Founders
Corporate information
Official name
OrbiMed Advisors Limited Liability Company
Registration country
Official name
OrbiMed Advisors Limited Liability Company
Registration country
Investment activity status
Active investor
Company type
American investment firm focused on making public and private investments in the healthcare and biotechnology industries.Overview
OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.
Funds managed
Team
Current employees
![]() |
Nissim Darvish |
Investments
Investment preferences
Investment focus themes
Selected investments
Company | Country | Date | Notes | ||
---|---|---|---|---|---|
![]() |
Blossomhill Therapeutics Inc Biotechnology company focused on oncology and autoimmune disorders. |
United States | 4 Mar 2021 | Series A Initial investment. Round participant. Active |
|
![]() |
Armo BioSciences Inc Late-stage immuno-oncology company. |
1 Sep 2017 | Series C-1 Follow-on investment. Round participant. Active |
||
![]() |
Nutrinia Ltd Developer of an oral formulation of insulin for intestinal malabsorption in preterm newborns and SBS in infants. |
Israel | 18 Aug 2016 | Series D Follow-on investment. Round participant. Active |
|
![]() |
Tricida Inc |
United Kingdom | 4 Mar 2015 4 Sep 2014 15 Jul 2016 |
Series C Follow-on investment. Round participant. Active |
|
![]() |
Natera Inc Biotechnology company providing preconception and prenatal genetic testing services. |
United States | 1 May 2013 | Venture Initial investment. Led the investment round. Active |
|
![]() |
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. |
United States | 1 Dec 2009 1 Dec 2011 1 Jun 2010 |
Series F Initial investment. Round participant. Active |
|
![]() |
Cleave Biosciences Inc Drug development company focused on novel targets in cellular protein homeostasis pathways |
United States | 1 Oct 2011 | Series A Active |
|
![]() |
Ambit Biosciences Inc A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer. |
United States | 10 Jun 2011 | Series D |
|
![]() |
Complete Genomics Inc |
United States | 1 Aug 2009 1 Aug 2010 |
Series E Active |
|
![]() |
Selecta Biosciences Inc A biotechnology company developing a new class of synthetic nanoparticle vaccines. |
United States | 5 Apr 2010 | Series C |
|
![]() |
Adimab LLC Developer of a human antibody discovery platform in yeast. |
United States | 1 Oct 2009 | Series D Active |
|
![]() |
Amnis Corp A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology. |
United States | 1 Jul 2009 | Series D |
|
![]() |
ARYx Therapeutics Inc |
United States | 1 Nov 2008 | N/A Initial investment. Round participant. Active |
|
![]() |
Biolex Therapeutics Inc |
United States | 1 Oct 2008 | Series D Active |
|
![]() |
Innovative Spinal Technologies Inc Spine technology company. |
United States | 8 Sep 2008 | Series C |